CTYPE html> ProCanBio | Biomarker Card

Biomarker Card

This biomarker card gives comprehensive information about each biomarker.
Detailed Information
Biomarker ID1915
PMID30396985
Year2018
BiomarkerProhibitin+ HSP27
Biomarker BasisExpression Based
BiomoleculeProtein
SourceTissue
SubjectsHumans
RegulationUpregulated in Metastatic PCa: [HSP27 (2.01 fold); prohibitin (1.88 fold); GSTP1 (1.18 fold); fibrinogen β chain (2.68 fold); ALDH6A1 (2.89 fold);] Downregulated in Metastatic PCa [A1AT (0.84 fold) ; HSP60 (0.19 fold);]
Odds Ratio/Hazard Ratio/Relative RiskNA
Effect on PathwaysNA
ExperimentSurvival Vs No Survival
Type of BiomarkerPrognostic
Cohort98 patients with metastatic Prostate Cancer were selected for analysis. 50 were alive and 48 were deceased
SenstivityNA
SpecificityNA
AUC0.7146
AccuracyNA
Level Of SignificanceNA
Method UsedImmunohistochemistry
ClinicalNo
RemarksNA
Clinical Trial NumberNA
Degree Of ValidityValidated on independent patient dataset
Technical NameNA